Brant Burden had a vision to improve blind nasotracheal intubation efficiency and safety. His vision became reality in 1997 when US Food and Drug Administration approved the Burden Nasoscope for human use. Full production at louisville Labs Inc. began in February 1998. Burden Nasoscope Recognized for its valuable contribution to blind nasotracheal intubation, the Burden Nasoscope will be incorporated into the 1998 revision of the Basic Trauma Life Support textbook at the recommendation of the BTLS program founder. Patients benefit from rapid tube placement, airway control, and ventilation.
Practitioners benefit from reduced exposure to body fluids and airborne pathogens.